Financial Wire

Truist表示,战争余波和春季销售淡季或将拖累房屋建筑商的盈利。

-- Truist Securities周四表示,受中东冲突带来的经济影响,几家美国主要房屋建筑商今年的盈利可能受到冲击,本已疲软的春季销售季更是雪上加霜。 这家券商下调了六家房屋建筑商下一季度和全年的盈利预期。这六家公司分别是D.R. Horton (DHI)、Meritage Homes (MTH)、NVR (NVR)、PulteGroup (PHM)、Taylor Morrison Homes (TMHC)和Toll Brothers (TOL)。 Truist还下调了这六家公司的目标股价,原因是通胀以及受2月底爆发的美以战争影响,油价上涨导致消费者信心下降。 Truist分析师Jonathan Bettenhausen在给客户的报告中表示:“这场战争的时机非常不巧。” “尽管我们认为业内对今年春季销售季的预期已经表明,销售额将比去年同期下降个位数百分比左右,但我们认为地缘政治环境的显著恶化不太可能被纳入这些预期之中。” 该券商表示,虽然他们预计其覆盖的股票中“不会有很多股票业绩超出预期”,但他们最看好的是泰勒·莫里森(Taylor Morrison),该股在最新季度财报发布前的表现尤为突出。贝滕豪森写道,这只股票可能“已经消化了最多的坏消息”。 这位分析师表示:“我们认为,人们对春季销售季的乐观情绪已经基本消散,因此我们相应地下调了(上半年)以及下半年的需求预期,因为春季(按订单生产)新订单需求预计会下降。” 由于3月份的新房销售和新住宅建设数据尚未公布,抵押贷款报告和谷歌趋势等其他市场指标“并未显示出令人鼓舞的需求趋势,我们认为,这证实了当前市场对需求的普遍看法。” 周三,全美住宅建筑商协会和富国银行表示,受经济不确定性、建材成本上涨和利率上升的影响,美国住宅建筑商信心指数本月跌至9月以来的最低点。 白宫对与伊朗达成协议持乐观态度,并指出第二轮谈判可能在巴基斯坦举行。上周末,美伊和平谈判在伊斯兰堡结束,但未达成协议。与此同时,华盛顿和德黑兰之间为期两周的停火协议仍然有效。

Price: $144.72, Change: $+0.52, Percent Change: +0.36%

Related Articles

Australia

Sector Update: Financial Stocks Softer Late Afternoon

Financial stocks fell in late Thursday afternoon trading with the NYSE Financial Index and the State Street Financial Select Sector SPDR ETF (XLF) each easing 0.2%.The Philadelphia Housing Index dropped 0.5%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) rose 0.8%.Bitcoin (BTC-USD) gained 0.4% to $75,140, and the yield for 10-year US Treasuries advanced 2.7 basis points to 4.309%.In economic news, US initial jobless claims last week fell to 207,000 from a downwardly revised 218,000 in the previous week, compared with expectations for a smaller decrease to 213,000 in a survey of analysts by Bloomberg.US industrial production fell by 0.5% in March, compared with expectations for a 0.1% increase in a Bloomberg survey, and following an upwardly revised 0.7% increase in February.The Philadelphia Federal Reserve's monthly manufacturing index rose to 26.7 in April after increasing to 18.1 in March, compared with expectations for a decline to 10 in a survey compiled by Bloomberg.The New York Federal Reserve's services index improved to minus 14 in April from minus 22.6 in March, compared with minus 20 expected in a survey compiled by Bloomberg.In regulatory news, the US Securities and Exchange Commission is seeking public comment in support of a comprehensive review of the Consolidated Audit Trail and other such audit trails used in the regulation of the country's securities markets.In corporate news, Charles Schwab's (SCHW) Q1 results rose amid a surge in client assets, even as revenue fell short of Wall Street's estimates. The shares fell 7.7%.Goldman Sachs (GS) rates-trading business faced pressure in Q1 as Iran-related market volatility led to losses on certain positions, Reuters reported. The bank posted a 10% drop in fixed-income, currencies and commodities revenue to $4 billion, driven by weaker results in interest-rate trading, mortgages, and credit products, the report said. Goldman shares were little changed.Marsh & McLennan (MRSH) shares climbed 4.6% after the company reported Q1 adjusted net income and revenue that surpassed analysts' estimates.The National Basketball Association is in early discussions with private credit firms, including Apollo Global Management (APO), Ares Management (ARES) and Sixth Street about funding a potential European basketball league expansion, Bloomberg reported. Apollo shares rose 0.1%, and Ares fell 2.7%.

$APO$ARES$GS$MRSH$SCHW
Japan

US Equity Indexes Advance After Trump Announces Israel-Lebanon Ceasefire Deal

US equity indexes rose ahead of Thursday's close after Israel and Lebanon agreed to a 10-day ceasefire, removing a major obstacle to the Middle East diplomacy for a lasting Iran truce deal.The Nasdaq Composite rose 0.2% to 24,069.1, with the S&P 500 up 0.2% to 7,035.2, and the Dow Jones Industrial Average higher by 0.2% to 48,583.5. Energy, real estate, and technology led the gainers. Health care was the worst performer.President Trump said the US might hold discussions with Iran this weekend, The Wall Street Journal reported. "We're very close to making a deal," the president told reporters outside the White House, according to the WSJ. Trump said he wasn't sure the current two-week ceasefire in the war would need to be extended, according to the report.Earlier on Thursday, Trump said on Truth Social that Lebanon and Israel have agreed to a 10-day ceasefire starting 5 pm ET. Lebanese Prime Minister Nawaf Salam said he welcomed the decision. In a follow-up social media post on Thursday, Trump said he will invite the Lebanese President, Joseph Aoun, and Israel's Prime Minister Benjamin Netanyahu to the White House for talks.Meanwhile, US Defense Secretary Pete Hegseth said Thursday that the naval blockade of Iran is an example of "polite" behavior during the ongoing ceasefire, and US forces are ready to strike power plants and the energy industry in the country, if ordered, according to a report from Reuters.West Texas Intermediate crude oil futures rose 2.5% to $93.77, and Brent crude futures jumped 3.7% to $98.58.

$^DJI$^IXIC$^SPX
Sectors

Sector Update: Health Care Stocks Decline Late Afternoon

Health care stocks were softer late Thursday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each decreasing 0.7%.The iShares Biotechnology ETF (IBB) dropped 1.3%.In corporate news, Abbott Laboratories (ABT) lowered its full-year earnings outlook on Thursday to reflect the acquisition of cancer diagnostics company Exact Sciences, while the healthcare firm reported Q1 results above market estimates. Its shares fell past 5%.Gilead Sciences (GILD) could beat Q1 consensus estimates, but weaker-than-expected persistence rates for Yeztugo point to a potential risk to long-term peak sales for the HIV pre-exposure prophylaxis drug, RBC Capital Markets said in a note. Gilead shares were down 0.8%.QuidelOrtho (QDEL) shares tumbled 28%. The company said late Wednesday it expects preliminary unaudited revenue of $615 million to $620 million for Q1. Analysts polled by FactSet expect $677.8 million.Hims & Hers Health (HIMS) shares jumped past 12% after a senior US health official signaled plans to ease restrictions on certain peptides.

$ABT$GILD$HIMS$QDEL